Loading clinical trials...
Loading clinical trials...
Multi-Center, Randomized, Controlled Evaluation of the Safety & Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
Conditions
Interventions
KXL System (15 mW/cm2)
KXL System (30 mW/cm2)
+2 more
Locations
83
United States
John Parker
Birmingham, Alabama, United States
Barnet Dulaney Perkins Eye Center
Phoenix, Arizona, United States
Advanced Vision Care
Los Angeles, California, United States
Stanford University School of Medicine
Palo Alto, California, United States
Grutzmacher, Lewis and Sierra
Sacramento, California, United States
Center for Sight
Sacramento, California, United States
Start Date
July 1, 2012
Primary Completion Date
January 1, 2016
Completion Date
August 1, 2016
Last Updated
July 5, 2018
NCT07372911
NCT06451718
NCT04439552
NCT02118922
NCT04094090
NCT03504800
Lead Sponsor
American-European Congress of Ophthalmic Surgery
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions